Viewpoint Molecular Targeting, Inc.
Amendment
CIK: 0001768245·Biotechnology·DELAWARE·Filed: Jan 15, 2021
Total Offering
$15,847,498
Amount Sold
$14,258,742
Investors
29
First Sale
Nov 20, 2020
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Frances Johnson | Related Person |
| Michael Schultz | Related Person |
| Heyward Coleman | Related Person |
| Curtis Nelson | Related Person |
| Cameron Gray | Related Person |
Company
SEC Filing
0001768245-21-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free